Elly Ryu - Jun 1, 2022 Form 4 Insider Report for Sesen Bio, Inc. (CARM)

Role
Principal Accounting Officer
Signature
/s/ Mark R. Sullivan, as attorney-in-fact
Stock symbol
CARM
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 07:22 PM
Previous filing
Feb 23, 2022
Next filing
Feb 23, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 1, 2022, the reporting person was awarded options to purchase 95,500 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vest date.